IGC Pharma (IGC) Change in Intangibles (2019 - 2025)
IGC Pharma (IGC) reported Change in Intangibles of $297000.0 for Q3 2025, up 471.15% year-over-year from $52000.0 in Q3 2024, and up 160.53% quarter-over-quarter from $114000.0 in Q2 2025.
IGC Pharma (IGC) Change in Intangibles (2019 - 2025) Analysis & Trends
IGC Pharma (IGC) has 7 years of Change in Intangibles data on file, last reported at $297000.0 in Q3 2025.
- Change in Intangibles for Q3 2025 came in at $297000.0, up 471.15% year-over-year; the trailing twelve-month figure through Sep 2025 was $636000.0 (up 34.18% YoY), and the FY2026 annual result was $169000.0, down 54.32% from the prior year.
- Change in Intangibles advanced to $297000.0 in Q3 2025 per IGC's latest filing, from $114000.0 in the prior quarter.
- Over five years, Change in Intangibles peaked at $498000.0 in Q1 2022 and troughed at $2000.0 in Q2 2021.
- A 5-year average of $106947.4 and a median of $52000.0 in 2024 frame the typical range for Change in Intangibles.
- The sharpest annual moves came in 2021 and 2022: Change in Intangibles slumped 92.31% in 2021, then soared 1560.0% in 2022.
- A 5-year view of Change in Intangibles shows it stood at $22000.0 in 2021, then jumped by 281.82% to $84000.0 in 2022, then sank by 77.38% to $19000.0 in 2023, then jumped by 305.26% to $77000.0 in 2024, then soared by 285.71% to $297000.0 in 2025.
- Business Quant data shows IGC's Change in Intangibles at $297000.0 in Q3 2025, $114000.0 in Q2 2025, and $148000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Intangibless (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 297,000.00 |
| Sep 30, 2025 | 297,000.00 |
| Jun 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 114,000.00 |
| Mar 31, 2025 | 148,000.00 |
| Mar 31, 2025 | 148,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Jun 30, 2024 | 93,000.00 |
| Jun 30, 2024 | 93,000.00 |
| Mar 31, 2024 | 310,000.00 |
| Mar 31, 2024 | 310,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 28,000.00 |
| Jun 30, 2023 | 28,000.00 |